Perfluorohexane Sulfonic Acid Disrupts the Immune Microenvironment for Spermatogenesis by Damaging the Structure of the Blood‐Testis Barrier in Mice
Advanced Science · 2025-03 · 12 (10)
DOI: 10.1002/advs.202409383 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 17.01.2025. Verfasst von Yan Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Reproductive Medicine and Offspring Health, Key Laboratory of Modern Toxicology of Ministry of Education, School of Public He…. Hauptthemen laut MEDLINE: Spermatogenesis, Blood-Testis Barrier, Fluorocarbons, Sulfonic Acids. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Natural Science Foundation of the Jiangsu Higher Education Institutions of China.
Abstract (Originalsprache)
Perfluorohexane sulfonic acid (PFHxS) is extensively used in waterproof coatings and fire‐fighting foams, and several studies have found it to be a potential health hazard, but there is still unknown about its effects on spermatogenesis. Our results showed that PFHxS‐treated mice have significant reproductive toxicity, including a decrease in sperm count and motility, and the levels of sex hormones ( P < 0.05). Concurrently, structural abnormalities are observed in sperm, affecting ≈60–75% of those in the PFHxS‐treated group. Additionally, it is found that the structure of the blood‐testis barrier (BTB) is damaged after PFHxS treatment, leading to higher expression levels of inflammatory cytokines in the microenvironment for spermatogenesis. Moreover, the expression of proteins associated with mitochondrial biogenesis, including PTEN‐induced kinase 1 (PINK1) and NADPH oxidase 4 (NOX4), is dysregulated in the testes after PFHxS treatment. Based on metabolome data, the differential metabolite 3‐hydroxybutanoic acid is identified in the PFHxS‐treated group, which can regulate the histone Kac levels, especially H3K4ac and H3K9ac. In summary, the results of this study suggest that in the testes of PFHxS‐treated mice, inflammatory factors disrupt the mitochondrial function and metabolic profiles and hinder the progress of gene transcription through histone Kac, ultimately causing sperm dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Reproductive Medicine and Offspring Health, Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, 211166, China.
- Department of Epidemiology, School of Public Health, Nantong University, Nantong, 226001, China.
ORCID-Profile: Chuncheng Lu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Natural Science Foundation of the Jiangsu Higher Education Institutions of China
Zitieren
APA
Zhang, Y., Shu, M., Shan, S., Liu, H., Zhang, Y., Song, C., Xu, Q., Fan, Y., & Lu, C. (2025). Perfluorohexane Sulfonic Acid Disrupts the Immune Microenvironment for Spermatogenesis by Damaging the Structure of the Blood‐Testis Barrier in Mice. Advanced Science, 12(10). https://doi.org/10.1002/advs.202409383
Vancouver
Zhang Y, Shu M, Shan S, Liu H, Zhang Y, Song C, et al. Perfluorohexane Sulfonic Acid Disrupts the Immune Microenvironment for Spermatogenesis by Damaging the Structure of the Blood‐Testis Barrier in Mice. Advanced Science. 2025;12(10). doi:10.1002/advs.202409383
BibTeX
@article{Zhang2025,
author = {Zhang, Yan and Shu, Mingxue and Shan, Shilin and Liu, Huiying and Zhang, Yucheng and Song, Chenyang and Xu, Qiaoqiao and Fan, Yun and Lu, Chuncheng},
title = {Perfluorohexane Sulfonic Acid Disrupts the Immune Microenvironment for Spermatogenesis by Damaging the Structure of the Blood‐Testis Barrier in Mice},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {10},
doi = {10.1002/advs.202409383}
}
EUVIMED